ScholarIQanswers from OpenAlex & ORCID
Paul Rutgeerts
ResearcherPublications, citations & collaboration network
Paul Rutgeerts is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Paul Rutgeerts have?
ScholarIQindexed works
Paul Rutgeerts has 879 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Paul Rutgeerts have?
ScholarIQcitation count
Paul Rutgeerts has 102,207 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Paul Rutgeerts?
ScholarIQh-index
Paul Rutgeerts has an h-index of 139 in OpenAlex.
What is the i10-index of Paul Rutgeerts?
ScholarIQi10-index
Paul Rutgeerts has an i10-index of 393 in OpenAlex.
What is the OpenAlex record for Paul Rutgeerts?
ScholarIQopenalex
The OpenAlex for Paul Rutgeerts is on the source record.
What are the most-cited papers on Paul Rutgeerts?
ScholarIQmost cited works
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands, Stephen B. Hanauer, Jean‐Frédéric Colombel, William J. Sandborn, Gert Van Assche, Jeffrey Axler, Hyo Jong Kim, Silvio Danese, Irving H. Fox, Catherine Milch, Serap Sankoh, Tim Wyant, Jing Xu, Asit Parikh
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Jeffrey C. Barrett, Sarah Hansoul, Dan L. Nicolae, Judy H. Cho, Richard H. Duerr, John D. Rioux, Steven R. Brant, Mark S. Silverberg, Kent D. Taylor, M. Michael Barmada, Alain Bitton, Themistocles Dassopoulos, Lisa W. Datta, Todd J. Green, Anne M. Griffiths, Emily O. Kistner, Michael T. Murtha, Miguel Regueiro, Jerome I. Rotter, L. Philip Schumm, A. Hillary Steinhart, Stephan R. Targan, Ramnik J. Xavier, Cécile Libioulle, Cynthia Sandor, Mark Lathrop, Jacques Bélaïche, Olivier Dewit, Marta Gut, Simon Heath, Debby Laukens, Myriam Mni, Paul Rutgeerts, A. Van Gossum, Diana Zélénika, Denis Franchimont, Jean‐Pierre Hugot, Martine De Vos, Séverine Vermeire, Édouard Louis, Lon R. Cardon, Carl A. Anderson, Hazel E. Drummond, Elaine R. Nimmo, Tariq Ahmad, Natalie J. Prescott, Clive M. Onnie, Sheila Fisher, Jonathan Marchini, Jilur Ghori, Suzannah Bumpstead, Rhian Gwilliam, Mark Tremelling, Panos Deloukas, John Mansfield, Derek P. Jewell, Jack Satsangi, Christopher G. Mathew, Miles Parkes, Michel Georges, Mark J. Daly
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Filip Baert, Maja Noman, Séverine Vermeire, Gert Van Assche, Geert D' Haens, An Carbonez, Paul Rutgeerts
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Brian G. Feagan, William J. Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R. Friedman, Marion Blank, Jewel Johanns, Long-Long Gao, Miao Ye, Omoniyi J. Adedokun, Bruce E. Sands, Stephen B. Hanauer, Séverine Vermeire, Stephan R. Targan, Subrata Ghosh, Willem J. de Villiers, Jean–Frédéric Colombel, Zsolt Tulassay, Ursula Seidler, Bruce Salzberg, Pierre Desreumaux, Scott D. Lee, Edward V. Loftus, Levinus A. Dieleman, Seymour Katz, Paul Rutgeerts
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death
Diether Lambrechts, Erik Storkebaum, Masafumi Morimoto, Jurgen Del‐Favero, Frederik Desmet, Stefan L. Marklund, Sabine Wyns, Vincent Thijs, Jörgen Andersson, Ingrid van Marion, Ammar Al‐Chalabi, Stéphanie Bornes, Rhiannon Musson, Valerie K. Hansen, L. Beckman, Rolf Adolfsson, Hardev Pall, Hervé Prats, Séverine Vermeire, Paul Rutgeerts, Shigehiro Katayama, Takuya Awata, Nigel Leigh, Loı̈c Lang-Lazdunski, Mieke Dewerchin, Christopher E. Shaw, Lieve Moons, Robert Vlietinck, Karen Morrison, Wim Robberecht, Christine Van Broeckhoven, Désiré Collen, Peter M. Andersen, Peter Carmeliet